Hidroksizin: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
Tidak ada ringkasan suntingan Tag: halaman dengan galat kutipan Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
||
(12 revisi perantara oleh pengguna yang sama tidak ditampilkan) | |||
Baris 10:
<!--Clinical data-->
| pronounce = {{IPAc-en|h|aɪ|ˈ|d|r|ɒ|k|s|ᵻ|z|iː|n}}
| tradename = Atarax,<ref>{{cite web | title=Atarax: FDA-Approved Drugs | website=U.S. [[Food and Drug Administration]] (FDA) | url=https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010392 | access-date=25 March 2023}}</ref> Vistaril,<ref>{{cite web|title=Vistaril: FDA-Approved Drugs|url=https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011459|access-date=5 August 2020|website=U.S. [[Food and Drug Administration]] (FDA) }}</ref>
| Drugs.com = {{drugs.com|monograph|hydroxyzine-hydrochloride}}
| MedlinePlus = a682866
Baris 18:
| pregnancy_category =
| dependency_liability = None <ref name=Hub2001>{{cite book | vauthors = Hubbard JR, Martin PR |title=Substance Abuse in the Mentally and Physically Disabled |date=2001 |publisher=CRC Press |isbn=9780824744977 |page=26 |url=https://books.google.com/books?id=MY1kFYk98mQC&pg=PA26 }}</ref>
| routes_of_administration = [[Oral
| class = [[First generation antihistamine]]<ref name=Chem2020/>
| ATC_prefix = N05
Baris 32:
<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound = 93%
| metabolism = [[
| metabolites = [[
| elimination_half-life = Dewasa: 20 jam<ref name="pmid2866055">{{cite journal | vauthors = Paton DM, Webster DR | title = Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines) | journal = Clinical Pharmacokinetics | volume = 10 | issue = 6 | pages = 477–497 | date = 1985 | pmid = 2866055 | doi = 10.2165/00003088-198510060-00002 | s2cid = 33541001 }}</ref><ref name="pmid6141198">{{cite journal | vauthors = Simons FE, Simons KJ, Frith EM | title = The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine | journal = The Journal of Allergy and Clinical Immunology | volume = 73 | issue = 1 Pt 1 | pages = 69–75 | date = January 1984 | pmid = 6141198 | doi = 10.1016/0091-6749(84)90486-x | doi-access = free }}</ref><br />Lansia: 29,3 jam<ref name="pmid2562944">{{cite journal | vauthors = Simons KJ, Watson WT, Chen XY, Simons FE | title = Pharmacokinetic and pharmacodynamic studies of the H1-receptor antagonist hydroxyzine in the elderly | journal = Clinical Pharmacology and Therapeutics | volume = 45 | issue = 1 | pages = 9–14 | date = January 1989 | pmid = 2562944 | doi = 10.1038/clpt.1989.2 | s2cid = 24571876 }}</ref><br />Anak-anak: 7,1 jam<ref name="pmid2866055" />
| excretion = [[
<!--Identifiers-->
Baris 76:
<!--Chemical data-->
| IUPAC_name = (±)-2-(2-<nowiki/>{4-[(4-
| C = 21
| H = 27
Baris 89:
}}
'''Hidroksizin'''
Hidroksizin bekerja dengan cara menghalangi efek
Obat ini pertama kali dibuat oleh [[UCB (perusahaan|Union Chimique Belge]] pada tahun 1956 dan disetujui untuk dijual oleh [[Pfizer]] di Amerika Serikat pada akhir tahun itu.
== Kimia ==
Baris 137 ⟶ 117:
[[Kategori:Etanolamina]]
[[Kategori:Senyawa 4-klorofenil]]
[[Kategori:Antihistamin]]
{{Farmasi-stub}}
|